Molecular Human Reproduction Vol. 2, NUMBER 5 pp. 327-334, 1996
© European Society of Human Reproduction and Embryology 1996
research-article |
Endocrinology and Paracrinology: Interference with follicle stimulating hormone regulation of human ovarian function*
Section of Reproductive Endocrinology and Fertility, Department of Obstetrics and Gynaecology, Dijkzigt Academic Hospital and Erasmus University Medical School Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
This review summarizes observations on the background and potential clinical significance of interference with follicle stimulating hormone (FSH) regulation of human ovarian function. This interference may occur at the level of the pituitary by the secretion of FSH isoforms with reduced or absent bioactivity. In addition, interference with FSH may occur in the circulation, or within the ovarian follicular compartment. Although the full range of its significance remains to be elucidated, there are distinct indications that these mechanisms may be involved in normal ovarian physiology, as well as in abnormal response of the ovary to stimulation by endogenous FSH or by exogenously-administered gonadotrophin preparations. Moreover, recent advances in the determination of the structure-function relationship of FSH and FSH-receptor interaction, in combination with new developments in recombinant DNA technology, will allow the production of modified FSH-or FSH receptor-like molecules with altered bioactivity. The availability of FSH agonists and antagonists in the near future should provide a challenge for clinicians to improve treatment outcome and to find new indications for the use of these compounds.
anti-FSH/bioactivity/FSH/follicle development/gonadotrophins
*Presented as an invited plenary lecture during the 11th Annual Meeting of the European Society for Human Reproduction and Embryology, Hamburg, 1995.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C.Y. Andersen, L. Leonardsen, A. Ulloa-Aguirre, J. Barrios-De-Tomasi, K.S. Kristensen, and A.G. Byskov Effect of different FSH isoforms on cyclic-AMP production by mouse cumulus-oocyte-complexes: a time course study Mol. Hum. Reprod., February 1, 2001; 7(2): 129 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Mayorga, J. Gromoll, H. M. Behre, C. Gassner, E. Nieschlag, and M. Simoni Ovarian Response to Follicle-Stimulating Hormone (FSH) Stimulation Depends on the FSH Receptor Genotype J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3365 - 3369. [Abstract] [Full Text] |
||||
![]() |
M. Simoni, J. Gromoll, and E. Nieschlag The Follicle-Stimulating Hormone Receptor: Biochemistry, Molecular Biology, Physiology, and Pathophysiology Endocr. Rev., December 1, 1997; 18(6): 739 - 773. [Abstract] [Full Text] |
||||
![]() |
I. Schipper, F. F. G. Rommerts, P. M. ten Hacken, and B. C. J. M. Fauser Low Levels of Follicle-Stimulating Hormone Receptor-Activation Inhibitors in Serum and Follicular Fluid from Normal Controls and Anovulatory Patients with or without Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1325 - 1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. J. M. Fauser and A. M. van Heusden Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences Endocr. Rev., February 1, 1997; 18(1): 71 - 106. [Abstract] [Full Text] |
||||


